King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain
DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.

Read more on News-Medical-Net

Related posts:

1. Chronic Lower Back Pain Sees New Treatment Trial
2. Low Back Stretch Routine Phase 2
3. King Clinic: Quincy chiropractor on LOW BACK and SCIATICA Pain
4. Brand New! Neck & Shoulder STRETCHES, Dr. Jeff King, Quincy chiropractor
5. Chronic Back Pain Relief - Which Treatment For Chronic Back Pain Works?